Procter & Gamble Recalls 30+ Products for Cancer-Causing Agent — How Was Stock Affected?

For many people, dry shampoo and dry conditioner are time-savers to maintain your style when you don’t want to wash your hair everyday — or simply don’t have the time. But Procter & Gamble recently recalled more than 30 aerosol spray haircare products that included dry shampoos and conditioners from lines including Pantene, Aussie, Herbal Essences and Waterl<ss in the United States. P&G issued the voluntary recall when it was discovered the products may contain benzene, a known carcinogen. Dozens of products were affected, according to CNN Business.

See: P&G Is the Latest Company To Hike Prices, Joining Coke, General Mills and Kimberly-Clark
Find: 5 Companies That Are Losing Money on Products and Thriving

In a statement, P&G said that it has not “received any reports of adverse events” and the products are not likely to contain enough benzene to cause health issues. However, the recall notice acknowledged, “Exposure to benzene can occur by inhalation, orally, and through the skin and it can result in cancers, including leukemia and blood cancer of the bone marrow and blood disorders which can be life-threatening.”  

Retailers have been asked to remove the products from store shelves. P&G customers with the products in their home can receive a full refund through an online form or by calling 1-888-674-3631 between 9 a.m. and 6 p.m. EST, Monday through Friday.

In November, P&G voluntarily recalled Old Spice and Secret deodorants for the same issue.

Building Wealth

See: The 25 Most Profitable Companies — and How Much They Make
Find: The Classic Brands You Love Are in Trouble

Following the recall on Dec. 17, P&G stock fell from a five-year high of $161.11 at market close on Dec. 16 to $156 at market open on Monday, Dec. 20. It began to climb mid-day Monday, hovering up 0.25% to $157.86 at market close.

As recently as October, financial experts at The Motley Fool called P&G stock “reliable” and a buy, with generous dividend yields of 2.4% and solid company fundamentals. The recent recalls are not the first challenge the company has faced, yet it maintains its 131-year streak of dividends. MarketBeat’s MarketRank calls the stock a “hold” right now, noting that its target buy price would be $149.57. In spite of the recent news surrounding the company, none of the analysts are rating it a “sell” right now, which shows that it’s often wiser to gauge investments by a company’s fundamentals and analyst reports rather than the latest headlines or whims of the marketplace.

More From GOBankingRates

Building Wealth

About the Author

Dawn Allcot is a full-time freelance writer and content marketing specialist who geeks out about finance, e-commerce, technology, and real estate. Her lengthy list of publishing credits include Bankrate, Lending Tree, and Chase Bank. She is the founder and owner of GeekTravelGuide.net, a travel, technology, and entertainment website. She lives on Long Island, New York, with a veritable menagerie that includes 2 cats, a rambunctious kitten, and three lizards of varying sizes and personalities – plus her two kids and husband. Find her on Twitter, @DawnAllcot.

Untitled design (1)
Close popup The GBR Closer icon

Sending you timely financial stories that you can bank on.

Sign up for our daily newsletter for the latest financial news and trending topics.

Loading...
Please enter an email.
Please enter a valid email address.
There was an unknown error. Please try again later.

For our full Privacy Policy, click here.